Cargando…

Development of an administrative definition for celiac disease

OBJECTIVE: The investigation and management of celiac disease places a high burden on the health care system. Accurate methods to ascertain cases of celiac disease (CD) in population-based administrative data can facilitate epidemiologic and health services research to guide disease management. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Duerksen, Donald R., Lix, Lisa M., Leslie, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798501/
https://www.ncbi.nlm.nih.gov/pubmed/31623688
http://dx.doi.org/10.1186/s13104-019-4693-2
_version_ 1783460060670722048
author Duerksen, Donald R.
Lix, Lisa M.
Leslie, William D.
author_facet Duerksen, Donald R.
Lix, Lisa M.
Leslie, William D.
author_sort Duerksen, Donald R.
collection PubMed
description OBJECTIVE: The investigation and management of celiac disease places a high burden on the health care system. Accurate methods to ascertain cases of celiac disease (CD) in population-based administrative data can facilitate epidemiologic and health services research to guide disease management. The study aim was to develop and validate administrative data case definitions for CD to facilitate further studies about the effect of CD on osteoporosis and fracture risk. RESULTS: Population-based data from the Manitoba Bone Mineral Density (BMD) Program registry, which contains medical information on all individuals in the province of Manitoba, Canada who have received BMD testing, was used to define the study cohort. Linked hospital discharge abstracts and physician billing claims were used to ascertain diagnoses of celiac disease in administrative data. A population-based CD serologic registry was used as the validation database. One diagnosis code in hospital discharge abstracts or two or more diagnosis codes in physician billing claims optimized the detection of positive celiac serology with sensitivity of 84% (95% CI 80–88%), specificity of 97% (95% CI 80–88%), PPV of 80% (95% CI 80–88%), and NPV of 97% (95% CI 80–88%). Our administrative data case definition for celiac disease demonstrates good sensitivity and specificity for detecting positive celiac serology.
format Online
Article
Text
id pubmed-6798501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67985012019-10-21 Development of an administrative definition for celiac disease Duerksen, Donald R. Lix, Lisa M. Leslie, William D. BMC Res Notes Research Note OBJECTIVE: The investigation and management of celiac disease places a high burden on the health care system. Accurate methods to ascertain cases of celiac disease (CD) in population-based administrative data can facilitate epidemiologic and health services research to guide disease management. The study aim was to develop and validate administrative data case definitions for CD to facilitate further studies about the effect of CD on osteoporosis and fracture risk. RESULTS: Population-based data from the Manitoba Bone Mineral Density (BMD) Program registry, which contains medical information on all individuals in the province of Manitoba, Canada who have received BMD testing, was used to define the study cohort. Linked hospital discharge abstracts and physician billing claims were used to ascertain diagnoses of celiac disease in administrative data. A population-based CD serologic registry was used as the validation database. One diagnosis code in hospital discharge abstracts or two or more diagnosis codes in physician billing claims optimized the detection of positive celiac serology with sensitivity of 84% (95% CI 80–88%), specificity of 97% (95% CI 80–88%), PPV of 80% (95% CI 80–88%), and NPV of 97% (95% CI 80–88%). Our administrative data case definition for celiac disease demonstrates good sensitivity and specificity for detecting positive celiac serology. BioMed Central 2019-10-17 /pmc/articles/PMC6798501/ /pubmed/31623688 http://dx.doi.org/10.1186/s13104-019-4693-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Duerksen, Donald R.
Lix, Lisa M.
Leslie, William D.
Development of an administrative definition for celiac disease
title Development of an administrative definition for celiac disease
title_full Development of an administrative definition for celiac disease
title_fullStr Development of an administrative definition for celiac disease
title_full_unstemmed Development of an administrative definition for celiac disease
title_short Development of an administrative definition for celiac disease
title_sort development of an administrative definition for celiac disease
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798501/
https://www.ncbi.nlm.nih.gov/pubmed/31623688
http://dx.doi.org/10.1186/s13104-019-4693-2
work_keys_str_mv AT duerksendonaldr developmentofanadministrativedefinitionforceliacdisease
AT lixlisam developmentofanadministrativedefinitionforceliacdisease
AT lesliewilliamd developmentofanadministrativedefinitionforceliacdisease